Biocon Biologics appoints Shreehas Tambe as MD and CEO

Last edition

Biocon Biologics appoints Shreehas Tambe as MD and CEO

Shreehas Tambe, the company's deputy CEO, has been promoted to managing director and CEO of Biocon Biologics.

Arun Chandavarkar, who will remain a non-executive, non-independent director on the company's board, is replaced by Tambe.

Since joining Biocon in 1997, Tambe has shaped and grown the company's biosimilars business and led the group's major capital expenditures, including the construction of its first plant outside of India in Malaysia.

Read more on:
Biocon Biologics Shreehas Tambe

More news about: industrial talks | Published by Sudeep Soparkar | December - 06 - 2022 | 330

Last news about this category

Aprotec Offers its Customers Turnkey Systems for Customised Applications

Cardiotrack Secures USD 2 Million in Pre-Series A Funding

Lupin Receives Approval from US FDA for Varenicline Tablets

Brenntag Specialties and Zeochem Expand Business Collaboration for Pharma EMEA

Cromatic Closes USD 5.3 Million in Oversubscribed Seed Round to Modernize Life Science R&D Outsourcing

Piramal Pharma Gets EIR from US FDA for Bethlehem Plant

Allcargo Supply Chain Launches State-Of-The Art Chemical Warehouse at Navi Mumbai

Great Place to Work Institute Certifies Thermo Fisher Scientific for Fifth Consecutive Year

Pharma Pro&Pack Expo, analytica Anacon India and India Lab Expo to Showcase Innovations in Pharma Processing Equipment and Laboratory Technology

Glenmark Pharmaceuticals in Process of Recalling 1,200 Bottles of Subpotent Hypertension Drug in USA

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy